Folkerts, Kerstin
Millier, Aurelie
Smela, Beata http://orcid.org/0000-0003-4896-9083
Olewinska, Elzbieta
Schmedt, Niklas
Mernagh, Paul
Kovesdy, Csaba P. http://orcid.org/0000-0002-8204-911X
Funding for this research was provided by:
Bayer
Article History
Received: 10 June 2022
Accepted: 10 October 2022
First Online: 23 November 2022
Declarations
:
: The study was funded by Bayer AG.
: CPK received honoraria for consultant work from Abbott, Akebia, AstraZeneca, Bayer, Boehringer-Ingelheim, Cara Therapeutics, CSL Behring, Reata, Rockwell, Takeda, Tricida and Vifor. AM, EO and BS are employees of Creativ-Ceutical which received funding from Bayer AG to conduct the study. KF and PM are employees of Bayer AG. NS was an employee of Bayer AG and is now an employee of Boehringer Ingelheim International GmbH. All of his work for this study was done under Bayer AG affiliation.